• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 298
  • 59
  • 16
  • 8
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 350
  • 350
  • 350
  • 79
  • 64
  • 48
  • 46
  • 41
  • 40
  • 40
  • 39
  • 37
  • 34
  • 32
  • 32
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Screening of recurrent BRCA gene mutations in Chinese breast and ovarian cancer

馮敬業, Fung, King-yip. January 2000 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
22

Methylation in colorectal cancer

陳安安, Chan, On-on, Annie. January 2002 (has links)
published_or_final_version / abstract / toc / Medicine / Master / Doctor of Medicine
23

Cytogenetic analysis of head and neck cancer by comparative genomic hybridization

錢文偉, Chien, Man-wai, Gary. January 2001 (has links)
published_or_final_version / Surgery / Master / Master of Philosophy
24

Molecular analysis of the human Fas gene in colorectal cancer / by Lisa Maree Butler.

Butler, Lisa Maree January 1998 (has links)
Errata pages inserted behind leaf 293. / Includes bibliography (leaves 255-293). / xv, 293, [60] leaves, [33] leaves of plates : ill. (some col.) ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Aims to determine the molecular mechanism by which expression of Fas is lost in colorectal tumours and investigates the effects of re-introducing Fas into colon cancer cells. An animal study was undertaken in addition to the studies of colorectal cancer, to investigate the role of Fas signalling in hormone-dependent involution of the prostate gland. / Thesis (Ph.D.)--University of Adelaide, Dept. of Surgery, 1998?
25

Molecular analysis of the human Fas gene in colorectal cancer / by Lisa Maree Butler.

Butler, Lisa Maree January 1998 (has links)
Errata pages inserted behind leaf 293. / Includes bibliography (leaves 255-293). / xv, 293, [60] leaves, [33] leaves of plates : ill. (some col.) ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Aims to determine the molecular mechanism by which expression of Fas is lost in colorectal tumours and investigates the effects of re-introducing Fas into colon cancer cells. An animal study was undertaken in addition to the studies of colorectal cancer, to investigate the role of Fas signalling in hormone-dependent involution of the prostate gland. / Thesis (Ph.D.)--University of Adelaide, Dept. of Surgery, 1998?
26

ANALYSIS OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR GENE AS A PROTO-ONCOGENE (SQUAMOUS CELL CARCINOMA).

HUNTS, JOHN HOWARD. January 1986 (has links)
The epidermal growth factor receptor (EGFR) gene was examined as a proto-oncogene. Initially, the cellular homolog of the retroviral oncogene erb-B was shown to be localized to the same region of human chromosome 7 as the EGFR gene, giving support to the idea that these genes are closely related. To determine how some cells can over-express the EGFR gene, somatic cell hybrids constructed between a human EGFR-overproducing cell line and a mouse EGFR-deficient cell line were examined. EGFR gene amplification was observed in one of these hybrids along with EGFR gene rearrangement, which is thought to generate an abnormal mRNA. When examining tumor tissue, the EGF receptor (EGFR) was found to be elevated relative to normal adjacent tissue in 9 out of 15 primary human squamous cell carcinomas. Only 2 of these 9 tumors had EGFR gene amplification, suggesting alternative mechanisms potentially involved in increasing EGFR levels. Because placental tissue expresses high levels of EGFR, it was thought that some tissues may normally possess high EGFR levels and that some cancerous tissues inappropriately mimic the mechanisms active in the placenta. From the examination of several tissue samples, EGFR mRNA levels and EGFR protein half-life were also postulated as contributing factors regulating the EGFR levels. The EGFR gene was implicated as a proto-oncogene by evidence which suggests that either a qualitative or a quantitative change in the receptor may be involved in tumorigenesis. Finally, to begin to better understand what role EGFR hyperproduction plays in tumorigenesis, a DNA vector was constructed which produces antisense-RNA for inhibiting EGFR expression.
27

Structural variation of the genome in breast cancer

Flach, Susanne January 2014 (has links)
No description available.
28

Subcellular localisation of growth suppressor protein deleted in livercancer 2 (DLC2)

Ng, Chi-heng, David., 吳志恒. January 2005 (has links)
published_or_final_version / abstract / Biochemistry / Master / Master of Philosophy
29

Identification and characterization of a novel tumor suppressor gene, delected in liver cancer 2, (DLC2)

Leung, Ho-yin, Thomas, 梁浩然 January 2005 (has links)
published_or_final_version / abstract / Pathology / Doctoral / Doctor of Philosophy
30

Study of the role of the tumor suppressor phosphatase and tensin homolog (PTEN) in hepatocellular carcinoma

Wong, Lai-ting, 王麗婷 January 2008 (has links)
published_or_final_version / Pathology / Master / Master of Philosophy

Page generated in 0.0805 seconds